GALAD score detects early HCC with strong accuracy

The GALAD score was superior to individual serum markers in detecting hepatocellular carcinoma in patients with nonalcoholic steatohepatitis, according to a case-control study published in Clinical Gastroenterology and Hepatology.“Surveillance of NASH patients for HCC is inadequate in particular as hepatocarcinogenesis may occur even in the absence of cirrhosis,” Jan Best, researcher at University Hospital Magdeburg, department of gastroenterology, hepatology and infectious disease in Magdeburg, Germany, and colleagues wrote. “In our international multicenter study, theRead More

Share on facebook
Share on twitter
Share on linkedin